Literature DB >> 873087

Relationship between heterogeneity of insulin responses and insulin resistance in normal subjects and patients with chemical diabetes.

G M Reaven, J M Olefsky.   

Abstract

Plasma insulin responses and insulin resistance were determined in 75 subjects, defined as having a normal, borderline abnormal, or abnormal oral glucose tolerance test (OGTT). Although considerable heterogeneity of insulin response existed, most patients with abnormal OGTT's had insulin responses greater than normal; none had insulin responses less than normal. The degree of insulin resistance also varied, but most patients with abnormal OGTT's were also abnormally insulin resistant A significant correlation (r=0.64, p+/-0.001) existed between insulin response and the degree of insulin resistance. However, when both variables were taken into consideration, the entire population could be divided into two groups. One group was characterized by both normal insulin responsiveness and sensitivity, the other by increased insulin response, associated with greater insulin resistance. Most patients with abnormal OGTT's fell into the latter group, but some had glucose intolerance without either an exaggerated insulin response or insulin resistance. These results suggest that true heterogeneity exists in patients with abnormal OGTT's.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 873087     DOI: 10.1007/bf01219700

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  24 in total

1.  Hyperinsulinemia and hypoinsulinemai. Insulin responses to oral carbohydrate over a wide spectrum of glucose tolerance.

Authors:  P J Savage; S E Dippe; P H Bennett; P Gorden; J Roth; N B Rushforth; M Miller
Journal:  Diabetes       Date:  1975-04       Impact factor: 9.461

2.  Reappraisal of the role of insulin in hypertriglyceridemia.

Authors:  J M Olefsky; J W Farquhar; G M Reaven
Journal:  Am J Med       Date:  1974-10       Impact factor: 4.965

3.  Does hyperglycaemia or hyperinsulinaemia characterise the patient with chemical diabetes?

Authors:  G M Reaven; J Olefsky; J W Farquhar
Journal:  Lancet       Date:  1972-06-10       Impact factor: 79.321

4.  Insulin and glucose responses to identical oral glucose tolerance tests performed forty-eight hours apart.

Authors:  J M Olefsky; G M Reaven
Journal:  Diabetes       Date:  1974-05       Impact factor: 9.461

5.  Excessive serum insulin response to oral glucose in obesity and mild diabetes. Study of 501 patients.

Authors:  R Chiles; M Tzagournis
Journal:  Diabetes       Date:  1970-06       Impact factor: 9.461

6.  Direct measurement of plasma proinsulin in normal and diabetic subjects.

Authors:  W C Duckworth; A E Kitabchi
Journal:  Am J Med       Date:  1972-10       Impact factor: 4.965

7.  Normal initial plasma insulin response in mild diabetes.

Authors:  K Johansen
Journal:  Metabolism       Date:  1972-12       Impact factor: 8.694

8.  Prospective study of 352 young patients with chemical diabetes.

Authors:  J B O'Sullivan; C M Mahan
Journal:  N Engl J Med       Date:  1968-05-09       Impact factor: 91.245

9.  Study of the relationship between glucose and insulin responses to an oral glucose load in man.

Authors:  G Reaven; R Miller
Journal:  Diabetes       Date:  1968-09       Impact factor: 9.461

10.  Age-adjusted analysis of insulin responses during normal and abnormal glucose tolerance tests in children and adolescents.

Authors:  A L Rosenbloom; L Wheeler; R Bianchi; F T Chin; C M Tiwary; A Grgic
Journal:  Diabetes       Date:  1975-09       Impact factor: 9.461

View more
  19 in total

1.  Pioglitazone improvement of fasting and postprandial hyperglycaemia in Mexican-American patients with Type 2 diabetes: a double tracer OGTT study.

Authors:  Leonard C Glass; Kenneth Cusi; Rachele Berria; Roberta Petz; Eugenio Cersosimo; Ralph A Defronzo; Amalia Gastaldelli
Journal:  Clin Endocrinol (Oxf)       Date:  2010-04-23       Impact factor: 3.478

Review 2.  Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis.

Authors:  C N Hales; D J Barker
Journal:  Diabetologia       Date:  1992-07       Impact factor: 10.122

3.  Quantitative and qualitative differences in basal and glucose- and arginine-stimulated insulin secretion in healthy subjects and different stages of NIDDM.

Authors:  K Ratheiser; W Reitgruber; M Komjati; P Bratusch-Marrain; H Vierhapper; W K Waldhäusl
Journal:  Acta Diabetol Lat       Date:  1990 Jul-Sep

4.  An attempt to define the nature of chemical diabetes using a multidimensional analysis.

Authors:  G M Reaven; R G Miller
Journal:  Diabetologia       Date:  1979-01       Impact factor: 10.122

5.  Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose.

Authors:  R N Bergman; L S Phillips; C Cobelli
Journal:  J Clin Invest       Date:  1981-12       Impact factor: 14.808

Review 6.  Pathogenesis of impaired glucose tolerance and type II diabetes mellitus--current status.

Authors:  M B Davidson
Journal:  West J Med       Date:  1985-02

7.  Evaluation of insulin resistance during inhibition of endogenous insulin and glucagon secretion by somatostatin in non-obese subjects with impaired glucose tolerance.

Authors:  K P Ratzmann; W Besch; S Witt; B Schulz
Journal:  Diabetologia       Date:  1981-09       Impact factor: 10.122

8.  Insulin secretion and insulin sensitivity defects are a common feature of mild, clinically homogeneous, recently diagnosed type II (non-insulin-dependent) diabetics.

Authors:  E Pisu; A Lombardi; D De Benedictis; C Bozzo; E Chiara; C Baggiore; A Bruno; L Cravero; G Pagano; G Lenti
Journal:  Acta Diabetol Lat       Date:  1986 Jul-Sep

9.  Oxidation of an exogenous glucose load using naturally labelled 13C-glucose. Effect of butylbiguanide therapy in obese mildly diabetic subjects.

Authors:  P Lefebvre; A Luyckx; F Mosora; M Lacroix; F Pirnay
Journal:  Diabetologia       Date:  1978-01-14       Impact factor: 10.122

10.  Heterogeneity of insulin responses: phases leading to type 2 (non-insulin-dependent) diabetes mellitus in the rhesus monkey.

Authors:  B C Hansen; N L Bodkin
Journal:  Diabetologia       Date:  1986-10       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.